This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk09: Good afternoon and welcome to the TriMet fourth quarter and full year 2021 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the start key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press start them on your telephone keypad. To withdraw your question, please press start them too. Please note this event is being recorded. I would now like to turn the conference over to Alex Bauer. Please go ahead.
spk01: Thank you, operator. Good afternoon, and welcome to Trinet's 2021 fourth quarter conference call. My name is Alex Bauer, and I am joined today by CEO Burton M. Goldfield and our CFO, Kelly Tuminelli. Before we begin, I would like to say a few words about forward-looking statements and our use of non-GAAP financial measures. Please note that today's discussion will include our 2022 first quarter and full year financial outlook and other statements that are not historical in nature, are predictive in nature, or depend upon or refer to future events or conditions, such as our expectations, estimates, predictions, strategies, beliefs, or other statements that might be considered forward-looking. These forward-looking statements are based on management's current expectations and assumptions and are inherently subject to risks, uncertainties, and changes in circumstances that are difficult to predict and that may cause actual results to differ materially from statements being made today or in the future. Acceptance may be required by law. We do not undertake to update any of these statements in light of new information, future events, or otherwise. We encourage you to review our most recent public filings with the SEC, including our 10-K and 10-Q filings for more detailed discussions of the risks, uncertainties, and changes in circumstances that may affect our future results or the market price of our stock. In addition, our discussion today will include non-GAAP financial measures, including our forward-looking guidance for adjusted net income per diluted share. For reconciliations of our non-GAAP financial measures to our GAAP financial results, please see our earnings release, 10-Q filings, or 10-K filing, which are available on our website or through the SEC website. With that, I will turn the call over to Burton. Burton?
spk05: Thank you, Alex. In terms of financial and operating performance, Trinet's fourth quarter was an exceptional quarter, capping off an exceptional year. 2021 was the strongest year in Trinet's history and pivotal for our company. In the fourth quarter, we delivered 16% year-over-year total revenues growth. And for the full year, we grew total revenues by 13%. we converted our strong organic revenue growth into tremendous earnings growth as we remain disciplined while managing our cost structure and systematically pricing our customers to risk. As a result, in the fourth quarter, we tripled our gap EPS to $1.03 and more than doubled our adjusted net income per share to $1.13. For the year, GAAP earnings per share came in at $5.07, up 27%, while adjusted net income per share came in at $5.64, up 27%. Strong cash generation in the quarter added to our already healthy balance sheet, and our board has increased our share repurchase authorization by $300 million, So as of today, we have repurchased capacity of more than $500 million. Trinet finished 2021 with approximately 365,000 WSEs, up 10% year over year. This WSE count represents an all time high for our company. Our growing resilient customer base comprised of SMBs in our core verticals of technology, life sciences, financial services, professional services, nonprofits, and select Main Street SMBs were critical in driving TriNet's financial performance. These clients continued to hire at an accelerated rate. This hiring is similar to the prior quarter, Q3, Furthermore, we realized increasing new sales volume and retention came in, in line with our Q4 internal expectations. At the start of the pandemic, the management team and I evaluated the changing market dynamics. We executed bold moves, including increasing investments in our verticalized customer acquisition strategy, and customer service approach, strengthening our tech platform and identifying inorganic opportunities to expand our total addressable market. Additionally, we benefited from consistently lower than forecast insurance cost ratios as the utilization of health services remained suppressed. We were able to positively impact customer retention by creating innovative, customer-centric programs such as our industry-leading recovery credit programs. These programs return funds to customers at a time when it was needed most during the height of the COVID-19 pandemic. These programs were possible because of our approach to designing the risk construct of our plans and pricing our customers to risk. We believe our approach is unique in the industry and there is no doubt that it allowed us to positively impact our customers in a very unique way. Turning to 2022 in the future, we have positioned Trinet for the next phase of growth beyond the pandemic. I want to spend the rest of my time today expanding on this by addressing what I am seeing in the market based on our direct experience with over 16,000 SMBs and the evolving customer lifecycle and how Trinet will continue to impact future growth of SMBs through our combined PEO HCM offering. I am passionate about the American small and mid-sized businesses, and I believe the future of the SMB market is brighter than it has ever been. I am confident the SMB market growth that we have experienced firsthand will continue for the foreseeable future. However, SMBs are seeing no relief from increasing regulatory complexities and the acquisition and retention of key talent remains a challenge. The landscape surrounding the state of the workforce and the way we work in America has changed inexorably during the COVID-19 pandemic. Employees are exhibiting greater agency over where they want to physically work. Employers are accommodating these requests. This trend creates added complexity, such as filing payroll taxes and ensuring HR compliance in multiple jurisdictions. Other new employment trends such as the great resignation are adding additional challenges. This is reshaping the competitive landscape for talent and therefore also the business landscape. My perspective is that rather than being the great resignation, what we are experiencing today is the great reevaluation. People feel more empowered to take stock of their situation and evaluate what they want out of life. This has created a greater willingness to make a career change. TriNet is in a unique position to help SMBs with the cultural, technological, and compliance-related support to allow our customers to be the beneficiaries of these re-evaluations as they aggressively compete for this talent. The strong employment growth in our installed customer base reaffirms that TriNet customers have successfully competed for talent and grown their organizations during this difficult period. Ultimately, TriNet strives to serve our customers throughout their entire business lifecycle. This includes bringing them in earlier and keeping them longer. Importantly, A customer's life cycle is rarely a simple process of growing from small to medium to large as measured by employee count or gross revenue. Moving to a multi-state workforce, changes in growth rates or funding strategies, and difficulty in hiring specific talent are examples of the types of complexities that SMBs experience. I believe the TriNet PEO construct has a unique advantage over all other SMB HCM product offerings for a particular set of SMBs. The co-employment legal construct, including our assumption of certain liabilities, continues to be a powerful growth and risk mitigation lever for SMBs who adopt this model. However, as customers grow, there is a heightened interest in transitioning from the PEO model because of either their scale or their global aspirations. Last month in January, Trinet saw this dynamic materialize at a higher rate than we have historically seen based on the changes in the growth and complexity that occurred during the pandemic. On one hand, I celebrate their success, but on the other hand, I can no longer accept valued customers growing out of us without a compelling alternative solution. Two wonderful customers embody this dynamic, Beyond Meat and Tonal. Beyond Meat is an innovative alternative protein company. The company went public in 2019 and enjoys a market capitalization in excess of $3 billion. Beyond Meat grew tremendously with Trinet, but in recent years, their business scaled sharply and their workforce expanded internationally. As such, Beyond Meat left Trinet. Having grown together for nearly 10 years, we wish them nothing but future success. Tonal is a fast-growing digital fitness company innovating the workout experience by leveraging technology for both the machine and the user experience. Tonal's rapid growth and expansion necessitated a more customized platform to accommodate a global workforce. We were so pleased to have grown with Tonal over the last six years and facilitate their growth. As Beyond Meat and Tonal move on, I want to reiterate my gratitude for our wonderful partnership over so many years. These relationships and a desire to serve these customers longer by providing a broader set of capabilities led directly to the pending acquisition of Zenefits, expected to close in the first quarter. Zenefits is a leading cloud-native human capital management software solution for SMBs. Through a centralized and highly scalable platform with modern consumer-like user interface, Zenefits is a complete HCM suite. The addition of this HCM software product to TriNet will allow us to address the opportunity to increase our ability to serve our addressable market, as well as providing optionality to our existing customers throughout their lifecycle. Ultimately, we view HCM software and the PEO offering as complementary with an opportunity to further leverage our scale in service of our customers. To be clear, this scale can be measured in different ways but is directly related to a combined customer base exceeding 23,000 clients and a workforce of more than 600,000 at the completion of the acquisition. Over time, we will work to evolve our platform to provide seamless, configurable access, allowing our customers greater optionality with respect to the services we offer. We will be in a position to address clients earlier in their life cycle and provide services as they continue to grow. Importantly, the Zenefits acquisition will enable us to more effectively go after the entire SMB TAM. The combination of Trinet and Zenefits should generate product and go-to-market synergies across the near, medium, and longer term. In the near term, we will leverage our complementary marketing funnels and brand reach to present the best solution that meets the prospect's needs. We believe we will benefit from this efficient go-to-market approach as we align prospects by product fit. We will leverage technology throughout the process, which should yield higher close rate. This is complementary to the current Zenefits go-to-market strategy that leverages technology and will thrive when at scale. In fact, they offer an easy-to-use user interface and a self-directed implementation. In the medium term, we see real opportunities as we align product capabilities to better serve our customers throughout their lifecycle. For example, Zenefits offers a robust digital benefit broker solution and exceptional health benefits administration platform that were both created with the SMB in mind. We believe these will augment and complement Trinet's own strong health and welfare offerings. In the long term, the combination of Trinet and Zenefits creates the opportunity for for Trinet to become the leading technology solutions provider for SMB human capital management with and without the PEO construct. Our vision for Trinet and Zenefits is to eventually offer HCM and PEO side by side with the same cloud-based technology stack. We intend to leverage technology from both companies and meet the diverse needs of all of our customers. This vision includes the use case where a dynamic Trinet customer can move between HCM software only and the PEO construct as their complexity and growth dictates. With the acquisition of Zenefits, Trinet is doing what no other HCM software solution is doing, combining a contemporary software product with an already scaled and successful PEO legal construct and service model. At Trinet, people matter is about putting human back into human capital management with a customer at the center of everything we do. We are excited to welcome the Zenefits team to Trinet. They bring additional innovation and entrepreneurial spirit to our company. We have strategically positioned Trinet for our next phase of growth. We look forward to updating you on these initiatives over time. With that, I will pass the call to Kelly for a review of our financials and our 2022 guidance. Kelly?
spk00: Thank you, Burton. Trinet's fourth quarter results capped off a year of extremely robust growth in financial performance. We finished the year with strong revenue and earnings growth. our highest ever WSE count, and significant operating cash flow, which enabled us to announce both the acquisition of Zenefits and an increase in our share repurchase authorization to over $500 million. We are well positioned to pursue our strategy and sustain our growth. During the fourth quarter, total revenue increased 16% year over year, outperforming the top end of our guidance range by two percentage points. For the full year, we grew total revenue by 13%, also exceeding guidance. The outperformance in total revenue for the fourth quarter and the full year was driven by growth in WSEs from strong hiring within our installed base, as well as an increase in net new sales, and we also had continued high health participation by our WSEs. Professional service revenues in the quarter grew 23% year over year, exceeding the top end of our guidance range by three percentage points. For the full year, professional services revenue grew by 17%, also above the top end of guidance. This growth in professional services revenue for the fourth quarter and full year was driven by a few factors. First, our year-over-year average volume growth of 10% for the quarter and 5% for the year reflected strong hiring, driven primarily by our technology, life sciences, and financial services verticals. Second, professional services revenue benefited from 10% growth in rate for the quarter and 9% for the full year. Like last quarter, rate growth saw a meaningful contribution from our efforts to achieve a minimum price with our smallest customers to align with the costs to serve those clients. We are near the end of our efforts to raise minimums, and now expect this to be largely incorporated in our overall rates and rate strategy going forward. Professional services revenue also benefited by 2% during the quarter versus Q4 2020, as last year's recovery credit accrual did not recur. For the fourth quarter, our insurance cost ratio was 88.7%, lower than our forecasted range for the quarter of 92 to 94%. For the full year, our insurance cost ratio was 85.6%, also slightly lower than our forecasted range for the year of 86.5% to 87%. The lower insurance cost ratio versus our estimate was largely due to two factors. First, elective procedures remain suppressed versus forecasted due to the continued impact from the COVID-19 Delta variant early in the quarter, and the emergence of the Omicron variant later in the quarter. While we did see a moderate spike in COVID testing and direct care claims during the quarter, these costs were more than offset by lower utilization. Second, we benefited from additional workers' compensation revenue given strong client growth, as well as wages and bonuses increasing for our WSEs. Regarding our operating expenses, we were modestly lower than our expectations for Q4 and continued to grow at a lower rate than our revenue, leveraging the scale of our operations. Now to earnings per share. Fourth quarter net income per diluted share exceeded guidance by 63 cents to $1.03, more than tripling year over year. This brought our full year gap net income per diluted share to $5.07, up 27% versus 2020. Fourth quarter adjusted net income per diluted share exceeded guidance by 53 cents to $1.13, more than doubling year over year. This brought full year adjusted net income per share to $5.64, also up 27% versus 2020. Our exceptional operating performance generated over $400 million in corporate operating cash flows and $565 million of adjusted EBITDA for the full year. This left us with over $600 million in corporate cash and positions us with an even stronger balance sheet poised to take advantage of strategic opportunities. Our capital priorities remain unchanged. We invest in our business for both organic and inorganic growth to take advantage of opportunities to grow TriNet, and we return cash to shareholders to maintain an efficient balance sheet. Both the announcement of the Zenefits acquisition and the $300 million increase to our share repurchase authorization are consistent with these priorities and highlight the continued strength of our balance sheet. Turning to Zenefits. Burton walked you through the strategic intent and fit of Zenefits, including how it fits within our overall product offering and how we believe it will accelerate our efforts to serve our customers throughout their lifecycle. I want to now take you through some of the financial aspects of the acquisition. In our 10-K filed aftermarket, you will find that our purchase price of approximately $220 million is made up of approximately $200 million in cash and $20 million in stock. Given our debt restructuring in 2021 and our strong cash generation, we will be using cash on hand to purchase Zenefits. An exciting opportunity with Zenefits is for Trinet to capitalize on our strong brand and utilize more of our marketing lead funnel. In other words, we can capture a larger portion of the SMB market than we would have otherwise. We are also excited by the opportunity for platform development and in a smaller way, leveraging back office support. We believe Zenefits will ultimately provide mid-teens return on invested capital. Before going into our 2022 outlook, I want to share some of the preliminary estimates for what we see as Zenefits contribution for 2022, recognizing we have yet to close the transaction. We expect Zenefits to contribute approximately $40 million to professional services revenue this year, assuming the transaction closes soon. As we pursue significant top-line growth at Zenefits, we anticipate a moderate operating loss for the first few years. We believe the Zenefits business can beat EBITDA breakeven by the third year and accretive on that basis thereafter. For 2022, we estimate Zenefits will reduce TriNet's adjusted net income per share by between 20 and 25 cents, or roughly six to seven cents per quarter. This estimate may be refined after the transaction is closed and purchase accounting is completed. Finally, we estimate Zenefits integration costs to be between 40 and $50 million before taxes in 2022. Given these costs are relatively one time in nature, we do expect to exclude these costs from non-GAAP adjusted net income per diluted share. Now let's turn to our 2022 first quarter and full year outlook, which excludes the numbers I just mentioned related to the acquisition of Zenefits. I will provide both GAAP and non-GAAP guidance. Overall, when we look at 2022, we believe the fundamentals of our PEO business will remain strong. Client hiring will continue to be robust as the economy fully recovers and grows, but moderate somewhat from the record levels we saw in 2021. As Burton mentioned earlier, we are anticipating attrition in 2022 to increase versus the very favorable rates we saw in 2020 and 2021. We anticipate returning closer to a pre-pandemic range as more of our largest clients that grew significantly during the pandemic graduate from the PEO model. In addition to the graduation of our largest clients, we expect to see continued elevated levels of M&A activity in IPOs. As a result, our volume forecast incorporates our anticipation of these ongoing trends. We expect to continue to optimize service prices at or above our costs, given continued product enhancements, and as a result, we expect to maintain strong margins with a more normalized insurance cost ratio. As we enter 2022, health experts have indicated the virus will become endemic. We believe this will ultimately lead to a return to a more historical insurance cost ratio range for us as routine care and elective procedures gradually resume. Turning to the first quarter of 2022, we expect total revenue growth to be in the range of 11 to 12% year-over-year and professional service revenue growth to be in a range of 16 to 17% year-over-year. This revenue growth reflects our strong finish to 2021 and the benefit of a higher ending WSE base. In Q1, we expect healthcare utilization to continue to remain below historical averages, especially early in the quarter as the Omicron variant peaked. This will result in a continued lower than normal insurance cost ratio of between 82 to 85% in the first quarter. This brings our estimate of first quarter gap net income per diluted share to be in the range of $1.71 to $2.03 per share and first quarter adjusted net income per diluted share to be in the range of $1.89 to $2.22 per share. Regarding our full year 2022 guidance, we're forecasting our year-over-year total revenue growth to be in a range of 4% to 7%, with our professional services revenue expected to grow between 6% and 9%. We expect our insurance cost ratios to follow seasonal patterns with favorable cost ratios in the first and second quarters as members work through deductibles and with higher cost ratios in the third and fourth quarters as deductibles are exhausted and pooling limits reset in October. With this trend, we expect our full year insurance cost ratio to be in the range of 88 to 89%. This ICR projection is about three points higher than our 2021 result, reflecting healthcare utilization returning to a range closer to historical levels. As a rule of thumb, every one-point movement in our 2022 expected ICR translates into approximately 45 cents in adjusted EPS. Given these anticipated trends, we expect full-year GAAP net income per diluted share to be in the range of $3.87 to $4.51 per share, and adjusted net income per diluted share to be in the range of $4.55 to to $5.20 per share. These expected ranges assume we execute share repurchases to offset overall dilution. With that, I will return the call to Burton for his closing remarks. Burton?
spk05: Thank you, Kelly. As I said at the beginning, 2021 was the strongest year in Trinet's history and pivotal for our company. We have taken action to position Trinet for the next decade of our growth. I am confident we have a compelling and differentiated vision for the future of PEO and HCM offerings rooted in our deep history with the best SMBs in America. With the acquisition of Zenefits, Trinet is doing what no other HCM software solution is doing, combining a contemporary software solution with an already scaled and successful PEO legal construct and service model. At Trinet, People Matter is about putting human back into human capital management with a customer at the center of everything we do. Over the past three years, which spans the pandemic, we have delivered exceptional earnings growth, top-line performance, and cash flow. We are committed to our disciplined pricing approach, which drove our profitable growth. and we will not compromise on this approach. Our resulting financial strength positioned us to opportunistically acquire Zenefits, which will now be part of the next chapter for TriNet, a chapter that includes the pursuit of the whole SMB TAM. Although 2022 sees us facing a year where presumably medical utilization normalizes, I could not be more excited about what the new year brings strategically to TriNet. In the quarters ahead, we will further expand and share our vision for TriNet's future. I am excited to welcome Zenefit's colleagues to TriNet and thank the TriNet colleagues for all their hard work and dedication that allowed us to deliver the best year in TriNet's history. Operator,
spk10: We will now begin the question and answer session.
spk09: To ask a question, you may press star then one in your telephone keypad. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two.
spk10: At this time, we'll pause momentarily to assemble our roster. Our first question comes from Tin Jin Wong with JP Morgan. You may now go ahead.
spk02: Thank you guys for all the... Hey, Burton. Good afternoon. Kelly, good afternoon. Thanks for all the details. A lot to go through. One question on the outlook and then one on benefits, if you don't mind. So on the outlook, can you maybe share a little bit more on your volume and rate assumption here? I hear you loud and clear on the higher attrition assumption, just trying to gauge how much of that is conservatism versus something that you're actually seeing on the ground today.
spk00: I appreciate the question, Tenjin. This is Kelly. I'll take it. When I think about attrition and volume forecasts, clearly it's all baked in. Probably 40% of our attrition for the year happens in the first quarter, and we get an indication of it in advance. So I feel good about the volume forecast that we have as we're building our revenue forecast, you know, so I, you know, I think it's pretty solid.
spk02: Okay. Okay. Yeah, no, I figured because with the enrollment season, I figured you'd get a little bit of visibility here. Okay. And then maybe for you, Burton, just on Zenefits, I hear the TAM or SMB. I'm curious really about the integration, you know, and the cultural differences between the two companies and, and how you anticipate meshing the two companies together from an integration standpoint. Any thoughts on that that you could share?
spk05: Yeah, absolutely. Absolutely recognizing, Tinsen, that it's not done yet. But, look, I see several opportunities. First and foremost, they will be operated separately. But what I see is new opportunities to drive sales for both Trinet PEO and Zenefits. Our brand is enjoying the highest recognition and the highest propensity to buy in my history here, according to Harris Poll. And the opportunity with leads coming in and efficiently sorting those leads so that the right product is delivered to the right customer at the right time makes me very optimistic about the near-term future to leverage our brand to provide leads to both companies. I think as you move forward, as I said in my prepared remarks, what gets me particularly excited is the idea of having a totally integrated platform that would allow customers to take a journey, and no two customer journeys are the same, where they could go from PEO to ASO and back, depending on the complexity, the need for our single employer plan, the need for the transfer of risk to Trinet, but using the same UI, the same back-end payroll engine, the same reporting engine, and really have that capability so you could serve a broader range of customers for a far longer period of time by taking them in earlier when it's not as complex and holding them longer as they so choose to bring in their own medical plans, et cetera. Mm-hmm.
spk02: Yeah, no, it sounds compelling. Definitely excited to learn more. Thanks for the update, guys.
spk06: Thank you.
spk02: Thanks for the update.
spk06: Thank you.
spk09: Our next question comes from Kevin McVeigh with Credit Suisse. You may now go ahead.
spk07: Great. Thanks so much. And let me add my congratulations on the transaction as well. Hey, I don't know if this would be for Kelly or Burton, but just following up on the benefits, one quick question um does the 2022 guidance include that revenue benefit from benefits and the dilution or is that something that gets adjusted after it's closed and then kelly if i heard you're right it sounded like 40 million of professional services is there any kind of cloud-based revenue in it today and if so what percentage is it
spk00: Yeah, Kevin, I'll take that for sure. Regarding guidance, if you look at our press release, all of the guidance published in the press release excludes Zenefits. So Zenefits, my comment on roughly 20 to 25 cent loss would be added to that. Regarding their revenue, it's all really cloud-based SaaS revenue as it's an ASO model. And what's that been growing, Kelly, like the $40 million?
spk07: Has that been growing historically?
spk00: Yeah, I'm not going to comment on their historical performance right now, but clearly we see them as a great growth opportunity for Trinet.
spk07: No, without a doubt, without a doubt. And I guess my only other question was, it seems like you're seeing a lot of success on the pricing side, And you've been able to layer in really, really good WSC growth as well. Is that a function of, you know, it sounds like you're repricing the Facebook. I thought you did some of that when you did the last integration. Is there just more potential upside there or just any thoughts on the pricing environment? And can you give us a sense of what pricing you have in the 2022 guidance? Happy to.
spk00: Happy to, Kevin. When I think about what we were able to achieve, it's a little bit nuanced in the fact that I think we got mid-single-digit price increases year over year, but we also got an overall benefit because one of the things I've talked about for a lot of this year, Kevin, is the fact that we had smaller customers that frankly cost us more to service, and we did reprice and put certain client-level minimums on those smaller customers to match the cost of serving them, and so that actually helped push the average up a little and make sure that all the clients really need the PEO services and risk transfer. As we're looking forward, we kind of see pricing in a similar range, mid-single-digit increase. As I'm thinking about professional service revenue particularly, And, you know, there will be other mix changes and things like that because we do have different products for different verticals. But, you know, on average, I would anticipate mid-single-digit price increase.
spk05: And, Kevin, I just wanted to add on top of that, if you don't mind, on the risk side of the business, one thing I can promise you is that we will remain disciplined in our pricing to risk. And I'm pretty proud of what the team did this year in a fairly tumultuous year. Because the problem is that if you don't maintain a disciplined approach to pricing, somebody ultimately pays for that. And it's either the shareholders or the client. So on both sides of this, I'm particularly proud of the year in terms of the growth, but equally proud of the pricing discipline.
spk08: Well, they should be, Burton, because it looks really, really strong, particularly if you're calibrating that risk, so congratulations.
spk06: Thank you so much, Kevin.
spk10: Again, if you have a question, please press star then 1.
spk09: Our next question comes from Andrew Nicholas with William Blair. You may now go ahead.
spk03: Thanks, and good afternoon. The first question I wanted to ask was just on increasing new sales volumes and momentum. Burton, would you mind kind of speaking to the drivers of that? Are win rates going up against, you know, competitive bake-offs? Is it about, you know, disruption post-COVID and maybe increased word of mouth and marketing? Just, you know, what under the hood is driving the new sales volumes? And is that a multi-year tailwind still in your view?
spk05: So, look, I can talk about Q4. We continued, Andrew, to see improvement new sales during the fourth quarter. I'm particularly pleased that we saw continued year-over-year ACV growth, and I think there's more room for improvement. What I am seeing is that the productivity on a per rep basis is better. Part of it, and I mentioned it a little bit earlier in the questions, is The brand awareness and brand recognition and propensity to buy has jumped dramatically year over year. Whether you equate that to people force, whether you equate that to getting the message out with a very professional and excellent sales force, whether you equate that to the customers we have today who use our product, referring us, in my mind, there's still a fantastic opportunity in the PEO business, and it's hard to predict where it's going, but right now the complexity is clearly driving an interest in the PEO model.
spk03: Makes sense. Thank you. And then maybe a follow-up for Kelly. First, just to confirm, there's no recovery credit in place for 2022, correct?
spk00: You are correct, Andrew. We have not made a determination to do a recovery credit program in 2022.
spk03: Okay. And then somewhat related, but only a little, I guess, is it fair to assume now with the ICR that that's more of a long-term rate? I heard a bunch of color on kind of your assumptions, and I think you mentioned that you're assuming COVID becomes a bit more endemic here. Is you know, the 88 to 89%, a good kind of long-term framework for us to think about, or is there still some noise that's specific to 2022 for us to keep in mind? Thank you.
spk00: Happy to answer the question, Andrew. When I think about 2022, you know, I've split it into right now in the first quarter, I expect a little bit of underutilization just given the continued Omicron variant and delayed delayed elective procedures. But as I think about, you know, 2023, 2024, those periods beyond, a few things I'd point out. One, we reprice to risk every single year. And so we will continue to look at experience and reprice to that risk. And given that, I would expect to be, you know, somewhere in the 88 to 90% range from an insurance class ratio.
spk06: Great, thank you.
spk11: Thank you, Andrew.
spk10: Our next question comes from David Grossman with Defo Financial. You may now go ahead.
spk04: Thank you, David. Hi, David. Good afternoon. I'm wondering if we could just go back to ZenoSense for a minute. Now you're going to own two technology platforms, one built to service the PO, you know, model and another built as more of a, you know, a software platform, you know, to be kind of a, not totally self-service, but more or less a self-service software platform. So if you think about where, how that evolves going forward, maybe it could help us understand what the technology roadmap looks like and what segments, you know, each platform serves going forward or, is a plan really to integrate the two so that as you, you know, you start on one platform and no matter, no matter how large you get, you stay on the same platform regardless.
spk05: So, so David, there'll be a lot more about this after we close the acquisition. But, but as I mentioned before, the idea of a single user interface, a single app, a single payroll engine, a single reporting engine, is where I would like to go. So you could seamlessly transition from either legal model to the other and enjoy the benefits of familiar input screens, familiar reports, and the ability to take advantage of whichever legal construct you want. Because after all, at the end of the day, they're all great SMBs. And with our PEO model, we serve a select group of those SMBs. And the Zenefits current platform serves another wider set of SMDs. So the idea of integrating them, obviously I've given it a lot of thought and I'm happy to talk more about it, but first I want to get the deal closed.
spk04: Got it. And then I guess going back to a comment, Kelly, you just made about really speaking to the cadence of the year. I think I understand your comment about the medical cost ratio. Is there anything else that happens on it, you know, that impacts the growth rate, because I haven't really built out a model yet, but to kind of see where the first quarter and how that impacts the implied growth for the balance of the year, but it seems obviously that it decelerates quite a bit. So is there anything else going on in queues two through four that impact growth besides that cost dynamic in healthcare?
spk00: We would expect to grow WSCs throughout the period. As I think about the pattern, like I mentioned, 40% of our attrition generally comes in the first quarter. It varies a little bit year to year, but we see the bulk of our attrition during the first quarter, and then we build back up as we add new clients onto our platform. So as I think about that pattern, I anticipate us to be lower from a WSC perspective after the first quarter, just like you saw last year, and then we would grow throughout the year.
spk04: Got it. And I guess just one other financial question. If I missed it, sorry, did you mention what the tax rate you're assuming for 2022? We did not mention a tax rate.
spk00: I wouldn't anticipate at this point that it would differ dramatically, but again, once we close the acquisition of Zenefits, we'll have to evaluate different state jurisdictions, et cetera, as we think about that going forward. But we're assuming for planning purposes a very similar tax rate.
spk04: Got it. All right, very good. Thank you, and good luck with the acquisition.
spk11: Thanks, David.
spk10: This concludes our question and answer session, as well as the conference. Thank you for attending today's presentation. You may now disconnect.
Disclaimer